Portfolio Holdings Detail for ISIN IE00BDZVHG35
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer Blackrock

ETF Ticker BTEE(USD) LSE
ETF Ticker BTEE.L(GBP) LSE

Holdings detail for NUVL

Stock Name	Nuvalent Inc
Ticker	NUVL(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US6707031075

Show aggregate NUVL holdings

News associated with NUVL

Nuvalent, Inc. (NASDAQ:NUVL) Receives Consensus Rating of “Buy” from Analysts: Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) has earned an average recommendation of “Buy” from the eleven ratings firms that are covering the company, Marketbeat Ratings reports. Ten investment analysts have rated the stock with a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among […] - 2025-08-29 02:14:49
Piper Sandler Begins Coverage on Nuvalent (NASDAQ:NUVL): Equities research analysts at Piper Sandler initiated coverage on shares of Nuvalent (NASDAQ:NUVL – Get Free Report) in a note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $112.00 price target on the stock. Piper Sandler’s price target indicates a potential upside of 52.92% from the stock’s previous […] - 2025-08-21 04:24:45
Nuvalent, Inc. (NASDAQ:NUVL) Shares Sold by Envestnet Asset Management Inc.: Envestnet Asset Management Inc. trimmed its holdings in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The institutional investor owned 6,520 shares of the company’s stock after selling 153 shares during the period. Envestnet Asset Management Inc.’s holdings in Nuvalent were worth $462,000 as of its most […] - 2025-08-07 05:02:59
Universal Beteiligungs und Servicegesellschaft mbH Sells 11,308 Shares of Nuvalent, Inc. (NASDAQ:NUVL): Universal Beteiligungs und Servicegesellschaft mbH cut its stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 20.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 45,255 shares of the company’s stock after selling 11,308 shares during the quarter. Universal Beteiligungs und […] - 2025-07-29 05:26:54
Head to Head Analysis: Nuvalent (NASDAQ:NUVL) vs. OnKure Therapeutics (NASDAQ:OKUR): OnKure Therapeutics (NASDAQ:OKUR – Get Free Report) and Nuvalent (NASDAQ:NUVL – Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their risk, institutional ownership, earnings, dividends, valuation, profitability and analyst recommendations. Analyst Ratings This is a breakdown of recent recommendations […] - 2025-07-25 05:56:58
Nuvalent (NASDAQ:NUVL) Given “Outperform” Rating at Wedbush: Wedbush reiterated their outperform rating on shares of Nuvalent (NASDAQ:NUVL – Free Report) in a research report sent to investors on Monday,RTT News reports. The brokerage currently has a $115.00 price target on the stock. NUVL has been the subject of a number of other reports. HC Wainwright reiterated a “buy” rating and set a […] - 2025-07-22 07:10:52
Henry E. Pelish Sells 5,500 Shares of Nuvalent, Inc. (NASDAQ:NUVL) Stock: Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) insider Henry E. Pelish sold 5,500 shares of the firm’s stock in a transaction dated Thursday, July 10th. The stock was sold at an average price of $79.98, for a total transaction of $439,890.00. Following the completion of the transaction, the insider owned 60,956 shares in the company, […] - 2025-07-14 05:12:52
The Goldman Sachs Group Upgrades Nuvalent (NASDAQ:NUVL) to Strong-Buy: The Goldman Sachs Group upgraded shares of Nuvalent (NASDAQ:NUVL – Free Report) to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports. A number of other research firms also recently issued reports on NUVL. Leerink Partners increased their price target on shares of Nuvalent from $125.00 to $140.00 and gave the […] - 2025-07-03 03:01:05
HC Wainwright Forecasts Strong Price Appreciation for Nuvalent (NASDAQ:NUVL) Stock: Nuvalent (NASDAQ:NUVL – Get Free Report) had its price target boosted by analysts at HC Wainwright from $110.00 to $130.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 64.37% from the company’s previous close. Separately, UBS Group […] - 2025-06-26 03:13:07
SG Americas Securities LLC Has $989,000 Holdings in Nuvalent, Inc. (NASDAQ:NUVL): SG Americas Securities LLC grew its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 29.2% during the 1st quarter, Holdings Channel.com reports. The firm owned 13,946 shares of the company’s stock after purchasing an additional 3,153 shares during the period. SG Americas Securities LLC’s holdings in Nuvalent were worth $989,000 as of its most […] - 2025-06-18 05:56:50
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 4.3% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 31,047 shares of the company’s stock after acquiring an additional 1,273 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Nuvalent were […] - 2025-05-22 05:52:58
Northern Trust Corp Buys 15,770 Shares of Nuvalent, Inc. (NASDAQ:NUVL): Northern Trust Corp grew its stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 4.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 335,550 shares of the company’s stock after purchasing an additional 15,770 shares during the period. Northern Trust Corp owned approximately […] - 2025-05-12 05:42:54
First Trust Advisors LP Raises Stake in Nuvalent, Inc. (NASDAQ:NUVL): First Trust Advisors LP lifted its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,542 shares of the company’s stock after purchasing an additional 1,685 shares during the period. […] - 2025-05-04 05:30:55
Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by Commonwealth Equity Services LLC: Commonwealth Equity Services LLC increased its holdings in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,618 shares of the company’s stock after purchasing an additional 309 shares during the period. […] - 2025-04-11 04:28:50
Sei Investments Co. Has $549,000 Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL): Sei Investments Co. trimmed its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 44.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,016 shares of the company’s stock after selling 5,659 shares during the period. Sei Investments Co.’s holdings in Nuvalent were worth $549,000 as of its most recent filing with […] - 2025-04-10 04:18:52
Corebridge Financial Inc. Decreases Stake in Nuvalent, Inc. (NASDAQ:NUVL): Corebridge Financial Inc. lessened its position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,472 shares of the company’s stock after selling 1,051 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-04 05:41:03
US Bancorp DE Makes New $90,000 Investment in Nuvalent, Inc. (NASDAQ:NUVL): US Bancorp DE acquired a new stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,156 shares of the company’s stock, valued at approximately $90,000. A number of other hedge funds have also modified […] - 2025-03-18 05:12:56
Nuvalent, Inc. (NASDAQ:NUVL) Holdings Lifted by abrdn plc: abrdn plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,701 shares of the company’s stock after purchasing an additional 9,241 shares during the quarter. abrdn plc owned about 0.08% of Nuvalent […] - 2025-02-10 16:42:58

iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) NUVL holdings

Date	Number of NUVL Shares Held	Base Market Value of NUVL Shares	Local Market Value of NUVL Shares	Change in NUVL Shares Held	Change in NUVL Base Value	Current Price per NUVL Share Held	Previous Price per NUVL Share Held
2025-12-03 (Wednesday)	46,717	USD 4,994,047	USD 4,994,047	0	USD 90,631	USD 106.9	USD 104.96
2025-12-02 (Tuesday)	46,717	USD 4,903,416	USD 4,903,416	1,665	USD 108,982	USD 104.96	USD 106.42
2025-12-01 (Monday)	45,052	USD 4,794,434	USD 4,794,434	0	USD -132,002	USD 106.42	USD 109.35
2025-11-28 (Friday)	45,052	USD 4,926,436	USD 4,926,436	111	USD 25,171	USD 109.35	USD 109.06
2025-11-27 (Thursday)	44,941	USD 4,901,265	USD 4,901,265	0	USD 0	USD 109.06	USD 109.06
2025-11-26 (Wednesday)	44,941	USD 4,901,265	USD 4,901,265	333	USD 630	USD 109.06	USD 109.86
2025-11-25 (Tuesday)	44,608	USD 4,900,635	USD 4,900,635	555	USD 75,510	USD 109.86	USD 109.53
2025-11-24 (Monday)	44,053	USD 4,825,125	USD 4,825,125	111	USD 172,546	USD 109.53	USD 105.88
2025-11-21 (Friday)	43,942	USD 4,652,579	USD 4,652,579	0	USD -93,596	USD 105.88	USD 108.01
2025-11-20 (Thursday)	43,942	USD 4,746,175	USD 4,746,175	-444	USD -8,897	USD 108.01	USD 107.13
2025-11-19 (Wednesday)	44,386	USD 4,755,072	USD 4,755,072	111	USD 139,846	USD 107.13	USD 104.24
2025-11-18 (Tuesday)	44,275	USD 4,615,226	USD 4,615,226	666	USD -94,546	USD 104.24	USD 108
2025-11-17 (Monday)	43,609	USD 4,709,772	USD 4,709,772	222	USD 522,926	USD 108	USD 96.5

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NUVL by Blackrock for IE00BDZVHG35

Show aggregate share trades of NUVL

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-02 BUY 1,665 106.980 103.510 103.857 USD 172,922 83.12
2025-11-28 BUY 111 109.455 107.190 107.417 USD 11,923 82.88
2025-11-26 BUY 333 110.925 107.790 108.104 USD 35,998 82.61
2025-11-26 BUY 333 110.925 107.790 108.104 USD 35,998 82.61
2025-11-25 BUY 555 111.240 107.960 108.288 USD 60,100 82.47
2025-11-24 BUY 111 112.110 106.860 107.385 USD 11,920 82.33
2025-11-20 SELL -444 108.010* 82.08 Profit of 36,444 on sale
2025-11-19 BUY 111 107.130* 81.95
2025-11-18 BUY 666 104.240* 81.83
2025-11-17 BUY 222 112.530 93.300 95.223 USD 21,140 81.70
2025-11-14 BUY 111 98.150 93.050 93.560 USD 10,385 81.62
2025-11-12 BUY 111 99.120 96.490 96.753 USD 10,740 81.47
2025-11-10 BUY 110 95.225 91.150 91.558 USD 10,071 81.33
2025-11-06 BUY 110 96.085 91.590 92.039 USD 10,124 81.18
2025-11-04 BUY 111 93.575 90.500 90.807 USD 10,080 81.07
2025-10-30 BUY 555 104.900 96.165 97.039 USD 53,856 80.81
2025-10-29 BUY 222 102.970 103.920 103.825 USD 23,049 80.68
2025-10-22 SELL -444 90.880 97.940 97.234 USD -43,172 80.27 Loss of -7,531 on sale
2025-10-20 BUY 222 97.970 98.540 98.483 USD 21,863 80.07
2025-10-17 BUY 554 92.520 92.900 92.862 USD 51,446 80.00
2025-10-15 BUY 880 89.640 90.230 90.171 USD 79,350 79.94
2025-10-03 BUY 770 84.220 84.788 84.731 USD 65,243 79.89
2025-10-02 BUY 110 83.860 84.060 84.040 USD 9,244 79.86
2025-09-30 BUY 220 86.480 86.755 86.727 USD 19,080 79.80
2025-09-26 BUY 220 81.390 81.780 81.741 USD 17,983 79.76
2025-09-25 BUY 220 77.520 79.610 79.401 USD 17,468 79.78
2025-09-18 BUY 114 80.960 81.670 81.599 USD 9,302 79.77
2025-09-17 BUY 345 78.640 81.275 81.012 USD 27,949 79.78
2025-07-17 SELL -230 85.690 86.830 86.716 USD -19,945 79.71 Loss of -1,612 on sale
2025-07-16 BUY 416 85.450 85.585 85.571 USD 35,598 79.67
2025-07-11 SELL -904 80.930 82.290 82.154 USD -74,267 79.61 Loss of -2,302 on sale
2025-07-02 BUY 6,215 80.500 80.895 80.855 USD 502,517 79.57
2025-06-25 BUY 226 79.090 79.970 79.882 USD 18,053 79.59
2025-06-20 BUY 1,061 75.000 76.243 76.119 USD 80,762 79.67
2025-06-11 BUY 220 76.910 79.900 79.601 USD 17,512 79.83
2025-06-10 BUY 220 79.460 79.680 79.658 USD 17,525 79.84
2025-06-04 SELL -110 76.820 78.820 78.620 USD -8,648 79.92 Profit of 143 on sale
2025-04-23 BUY 110 72.710 74.280 74.123 USD 8,154 81.88
2025-04-10 SELL -880 61.990 65.875 65.487 USD -57,628 83.15 Profit of 15,543 on sale
2025-04-08 SELL -110 59.320 68.445 67.532 USD -7,429 83.63 Profit of 1,771 on sale
2025-04-07 SELL -110 64.680 66.640 66.444 USD -7,309 83.85 Profit of 1,915 on sale
2025-04-04 SELL -550 65.740 68.035 67.806 USD -37,293 84.07 Profit of 8,944 on sale
2025-04-01 BUY 962 68.000 72.610 72.149 USD 69,407 84.43
2025-03-31 SELL -324 70.920 72.850 72.657 USD -23,541 84.59 Profit of 3,866 on sale
2025-03-21 BUY 1,419 77.960 78.770 78.689 USD 111,660 85.34
2025-03-14 SELL -1,648 77.010 78.230 78.108 USD -128,722 85.91 Profit of 12,862 on sale
2025-03-07 SELL -206 71.070 73.210 72.996 USD -15,037 87.03 Profit of 2,891 on sale
2025-03-04 SELL -103 71.610 72.530 72.438 USD -7,461 87.74 Profit of 1,576 on sale
2025-02-25 BUY 206 75.890 78.100 77.879 USD 16,043 88.86
2025-02-19 SELL -103 80.260 80.390 80.377 USD -8,279 89.51 Profit of 941 on sale
2025-02-13 BUY 309 80.950 84.800 84.415 USD 26,084 90.35
2025-02-12 BUY 103 81.240 82.440 82.320 USD 8,479 90.54
2025-02-11 BUY 412 82.900 83.800 83.710 USD 34,489 90.70
2025-01-02 BUY 308 79.990 80.770 80.692 USD 24,853 93.09
2024-12-30 SELL -510 77.870 80.720 80.435 USD -41,022 93.55 Profit of 6,689 on sale
2024-11-18 SELL -1,530 87.690 89.040 88.905 USD -136,025 93.08 Profit of 6,390 on sale
2024-11-08 SELL -102 95.420 95.600 95.582 USD -9,749 93.06 Loss of -257 on sale
2024-10-30 BUY 311 90.240 91.090 91.005 USD 28,303 95.05
2024-10-21 SELL -101 101.165 104.440 104.113 USD -10,515 0.00 Loss of -10,515 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-02	BUY	1,665	106.980	103.510	103.857	USD 172,922	83.12
2025-11-28	BUY	111	109.455	107.190	107.417	USD 11,923	82.88
2025-11-26	BUY	333	110.925	107.790	108.104	USD 35,998	82.61
2025-11-26	BUY	333	110.925	107.790	108.104	USD 35,998	82.61
2025-11-25	BUY	555	111.240	107.960	108.288	USD 60,100	82.47
2025-11-24	BUY	111	112.110	106.860	107.385	USD 11,920	82.33
2025-11-20	SELL	-444			108.010*		82.08 Profit of 36,444 on sale
2025-11-19	BUY	111			107.130*		81.95
2025-11-18	BUY	666			104.240*		81.83
2025-11-17	BUY	222	112.530	93.300	95.223	USD 21,140	81.70
2025-11-14	BUY	111	98.150	93.050	93.560	USD 10,385	81.62
2025-11-12	BUY	111	99.120	96.490	96.753	USD 10,740	81.47
2025-11-10	BUY	110	95.225	91.150	91.558	USD 10,071	81.33
2025-11-06	BUY	110	96.085	91.590	92.039	USD 10,124	81.18
2025-11-04	BUY	111	93.575	90.500	90.807	USD 10,080	81.07
2025-10-30	BUY	555	104.900	96.165	97.039	USD 53,856	80.81
2025-10-29	BUY	222	102.970	103.920	103.825	USD 23,049	80.68
2025-10-22	SELL	-444	90.880	97.940	97.234	USD -43,172	80.27 Loss of -7,531 on sale
2025-10-20	BUY	222	97.970	98.540	98.483	USD 21,863	80.07
2025-10-17	BUY	554	92.520	92.900	92.862	USD 51,446	80.00
2025-10-15	BUY	880	89.640	90.230	90.171	USD 79,350	79.94
2025-10-03	BUY	770	84.220	84.788	84.731	USD 65,243	79.89
2025-10-02	BUY	110	83.860	84.060	84.040	USD 9,244	79.86
2025-09-30	BUY	220	86.480	86.755	86.727	USD 19,080	79.80
2025-09-26	BUY	220	81.390	81.780	81.741	USD 17,983	79.76
2025-09-25	BUY	220	77.520	79.610	79.401	USD 17,468	79.78
2025-09-18	BUY	114	80.960	81.670	81.599	USD 9,302	79.77
2025-09-17	BUY	345	78.640	81.275	81.012	USD 27,949	79.78
2025-07-17	SELL	-230	85.690	86.830	86.716	USD -19,945	79.71 Loss of -1,612 on sale
2025-07-16	BUY	416	85.450	85.585	85.571	USD 35,598	79.67
2025-07-11	SELL	-904	80.930	82.290	82.154	USD -74,267	79.61 Loss of -2,302 on sale
2025-07-02	BUY	6,215	80.500	80.895	80.855	USD 502,517	79.57
2025-06-25	BUY	226	79.090	79.970	79.882	USD 18,053	79.59
2025-06-20	BUY	1,061	75.000	76.243	76.119	USD 80,762	79.67
2025-06-11	BUY	220	76.910	79.900	79.601	USD 17,512	79.83
2025-06-10	BUY	220	79.460	79.680	79.658	USD 17,525	79.84
2025-06-04	SELL	-110	76.820	78.820	78.620	USD -8,648	79.92 Profit of 143 on sale
2025-04-23	BUY	110	72.710	74.280	74.123	USD 8,154	81.88
2025-04-10	SELL	-880	61.990	65.875	65.487	USD -57,628	83.15 Profit of 15,543 on sale
2025-04-08	SELL	-110	59.320	68.445	67.532	USD -7,429	83.63 Profit of 1,771 on sale
2025-04-07	SELL	-110	64.680	66.640	66.444	USD -7,309	83.85 Profit of 1,915 on sale
2025-04-04	SELL	-550	65.740	68.035	67.806	USD -37,293	84.07 Profit of 8,944 on sale
2025-04-01	BUY	962	68.000	72.610	72.149	USD 69,407	84.43
2025-03-31	SELL	-324	70.920	72.850	72.657	USD -23,541	84.59 Profit of 3,866 on sale
2025-03-21	BUY	1,419	77.960	78.770	78.689	USD 111,660	85.34
2025-03-14	SELL	-1,648	77.010	78.230	78.108	USD -128,722	85.91 Profit of 12,862 on sale
2025-03-07	SELL	-206	71.070	73.210	72.996	USD -15,037	87.03 Profit of 2,891 on sale
2025-03-04	SELL	-103	71.610	72.530	72.438	USD -7,461	87.74 Profit of 1,576 on sale
2025-02-25	BUY	206	75.890	78.100	77.879	USD 16,043	88.86
2025-02-19	SELL	-103	80.260	80.390	80.377	USD -8,279	89.51 Profit of 941 on sale
2025-02-13	BUY	309	80.950	84.800	84.415	USD 26,084	90.35
2025-02-12	BUY	103	81.240	82.440	82.320	USD 8,479	90.54
2025-02-11	BUY	412	82.900	83.800	83.710	USD 34,489	90.70
2025-01-02	BUY	308	79.990	80.770	80.692	USD 24,853	93.09
2024-12-30	SELL	-510	77.870	80.720	80.435	USD -41,022	93.55 Profit of 6,689 on sale
2024-11-18	SELL	-1,530	87.690	89.040	88.905	USD -136,025	93.08 Profit of 6,390 on sale
2024-11-08	SELL	-102	95.420	95.600	95.582	USD -9,749	93.06 Loss of -257 on sale
2024-10-30	BUY	311	90.240	91.090	91.005	USD 28,303	95.05
2024-10-21	SELL	-101	101.165	104.440	104.113	USD -10,515	0.00 Loss of -10,515 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NUVL

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	71,180	0	91,144	78.1%
2025-09-18	52,005	0	71,961	72.3%
2025-09-17	91,414	0	108,410	84.3%
2025-09-16	62,363	25	79,412	78.5%
2025-09-15	144,559	11,459	178,643	80.9%
2025-09-12	96,006	0	146,686	65.5%
2025-09-11	140,353	0	179,917	78.0%
2025-09-10	115,825	0	131,864	87.8%
2025-09-09	65,384	49	84,353	77.5%
2025-09-08	151,430	100	169,010	89.6%
2025-09-05	84,737	40	126,840	66.8%
2025-09-04	118,297	50	143,875	82.2%
2025-09-03	172,398	400	368,587	46.8%
2025-09-02	139,902	19	264,906	52.8%
2025-08-29	122,469	0	169,215	72.4%
2025-08-28	93,076	4,542	145,189	64.1%
2025-08-27	43,710	0	58,038	75.3%
2025-08-26	98,627	0	111,839	88.2%
2025-08-25	50,515	3,508	60,744	83.2%
2025-08-22	71,646	0	93,459	76.7%
2025-08-21	119,590	0	146,372	81.7%
2025-08-20	142,057	0	157,455	90.2%
2025-08-19	103,367	0	121,909	84.8%
2025-08-18	148,615	1,340	195,876	75.9%
2025-08-15	121,565	13,917	142,967	85.0%
2025-08-14	81,547	0	90,249	90.4%
2025-08-13	79,956	0	91,953	87.0%
2025-08-12	79,180	0	93,307	84.9%
2025-08-11	208,743	0	331,558	63.0%
2025-08-08	157,044	4	499,990	31.4%
2025-08-07	183,210	70	283,219	64.7%
2025-08-06	79,040	117	148,186	53.3%
2025-08-05	81,698	0	187,487	43.6%
2025-08-04	88,289	82	158,467	55.7%
2025-08-01	79,833	663	104,432	76.4%
2025-07-31	99,882	0	130,175	76.7%
2025-07-30	64,175	2,600	85,942	74.7%
2025-07-29	72,077	2	158,008	45.6%
2025-07-28	129,580	2,165	229,240	56.5%
2025-07-25	269,988	0	645,797	41.8%
2025-07-24	58,732	216	133,052	44.1%
2025-07-23	40,296	2,711	84,790	47.5%
2025-07-22	68,082	0	106,341	64.0%
2025-07-21	69,195	95	116,549	59.4%
2025-07-18	77,990	45	135,275	57.7%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Issuer	Blackrock
ETF Ticker	BTEE(USD) LSE
ETF Ticker	BTEE.L(GBP) LSE